liraglutide glp 1 analogue Liraglutide, a long-acting cardioprotective glucagon-like peptide (GLP)-1 analogue, was approved in 2017 for the treatment of type 2 diabetes, contributing to medical weight loss and glycaemic control in patients. It is indicated Liraglutide vs Semaglutide GLP-1 vs
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



























